Reports reaching ICInsider.com is the chairman of Elite Diagnostic acquired more than 35 million shares on Friday, with the majority coming from Excel Investments, that owned the largest block of 130 million or 36.9 percent of issued shares.
The trade means that Gooden, who previously owned a mere 242,230 or a fraction of one percent, will now own around 10 percent of the company, the third largest shareholder behind Excel with 85,231,108 units and NCB Capital Market with 66 million shares or 18 percent.
Gooden, a very knowledgeable person in the investment field, also heads NCB Capital Market and controls the largest block of shares in the company of 28 percent, compared to Excel with 27 percent.
The Elite Diagnostic trade was the largest block of shares trading on Friday, accounting for 76.5 percent of all Junior Market trades on that day, but trading ended with 85.2 million units on the offer to sell at $2.57 and 30 million on the bid to buy at $2.50. ICInsider.com gathers that the amount on offer is not up for sale and should have been cancelled before the market closed.
The purchase is a strong endorsement for the stock and the company’s future that ended as the number one choice in this weeks’ ICTOP10 Junior Market listing.
The results for the second quarter to December stated, “continued spread of the Coronavirus disease (COVID-19) continued to negatively impact the operations of the company. Revenue continues to be impacted as social distancing protocols reduce the number of patients booked per day.”
Elite CEO Warren Chung & shareholder in Excel Investments chatting with a shareholder at Elite’s 2018 AGM.
ICInsider.com understands that the restriction placed for curfews restricted business as the offices could not be opened late, thus affecting business.
Gooden most likely would have seen the prolonged trend of year over year and quarter over quarter growth in revenues and the strong positive cash flow the company continues to generate and prospects for more expansion of the business as solid credentials for future earnings and profit.
For the six months to December last year, the company generated a profit of $7 million but had positive cash inflows of $83 million, with revenues rising 22 percent from $236 million to $288 million with eth December quarter rising 16.6 percent from $128 million to $148 million. Profit in the second quarter increased from $3 million in 2020 to $7.3 million. Importantly gross profit margin is an astounding and attractive 66 percent.
